Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q1 2026 · 10-Q
Revenue$12.13M$12.13M+42.9% vs Q1 2025 Net Income-$9.55M-$9.55MN/M vs Q1 2025 EPS Diluted-$0.32-$0.32N/M vs Q1 2025 Gross Profit$7,756,000+51.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flow-$7,967,000N/M Free Cash Flowderived-$8,612,000N/M Margins · derivedGross margin64.0%+3.5 pt vs Q1 2025
Operating margin-69.9%+2.7 pt vs Q1 2025
Net margin-78.8%−7.7 pt vs Q1 2025
ended Mar 31, 2026 · filed May 13, 2026 · 43 d after period end